CardiovascularCARDIOGEN
20MG
$70
Description
Cardiogen is a bioregulatory tripeptide (Ala-Glu-Asp) developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology. It is part of the Khavinson class of short peptide bioregulators that target specific organ systems through epigenetic mechanisms. Cardiogen specifically targets cardiac (heart) tissue, promoting cardiomyocyte function, myocardial repair, and cardiovascular tissue maintenance. It works at the gene expression level to normalize protein synthesis in heart muscle cells, supporting the structural integrity and functional capacity of cardiac tissue. Cardiogen is particularly relevant to aging and cardiovascular research, as cardiac function decline is a major factor in age-related disease.
Potential Benefits
Research Notes
Cardiogen was developed as part of the Khavinson peptide bioregulation program. Published studies in the Bulletin of Experimental Biology and Medicine and Advances in Gerontology demonstrate that short bioregulatory peptides like Cardiogen can interact with DNA to modulate tissue-specific gene expression in cardiac cells. Research shows improvements in cardiac function markers and myocardial tissue health in aging models. Molecular formula: C43H50N10O13. CAS number: 119142-63-5.
Usage Information
For research and educational purposes only. Consult with a qualified professional before use.
All peptides must be refrigerated upon receipt.
RESEARCH PURPOSES ONLY
This product is intended for research and educational purposes only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.